ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2022

Lysophosphatidylcholine (17:0) Improves HFD-Induced Hyperglycemia & Insulin Resistance: A Mechanistic Mice Model Study.

Li Bao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.